NYSE - Delayed Quote USD

McKesson Corporation (MCK)

Compare
561.08 +5.64 (+1.02%)
At close: August 30 at 4:00 PM EDT
562.50 +1.42 (+0.25%)
After hours: August 30 at 7:39 PM EDT
Loading Chart for MCK
DELL
  • Previous Close 555.44
  • Open 556.00
  • Bid 561.43 x 800
  • Ask 562.02 x 1000
  • Day's Range 555.17 - 562.41
  • 52 Week Range 404.72 - 637.51
  • Volume 954,165
  • Avg. Volume 772,955
  • Market Cap (intraday) 72.759B
  • Beta (5Y Monthly) 0.45
  • PE Ratio (TTM) 25.06
  • EPS (TTM) 22.39
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield 2.84 (0.51%)
  • Ex-Dividend Date Aug 30, 2024
  • 1y Target Est 628.97

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

www.mckesson.com

45,000

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MCK

View More

Performance Overview: MCK

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MCK
21.62%
S&P 500
18.42%

1-Year Return

MCK
33.91%
S&P 500
25.59%

3-Year Return

MCK
184.55%
S&P 500
25.26%

5-Year Return

MCK
323.57%
S&P 500
93.14%

Compare To: MCK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MCK

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    72.76B

  • Enterprise Value

    77.85B

  • Trailing P/E

    25.08

  • Forward P/E

    17.54

  • PEG Ratio (5yr expected)

    1.62

  • Price/Sales (ttm)

    0.24

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.25

  • Enterprise Value/EBITDA

    16.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.94%

  • Return on Assets (ttm)

    4.24%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    313.75B

  • Net Income Avi to Common (ttm)

    2.96B

  • Diluted EPS (ttm)

    22.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.76B

Research Analysis: MCK

View More

Company Insights: MCK

Research Reports: MCK

View More

People Also Watch